Imagion Biosystems Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:IBXHealthcare
Country Australia
PE (Fwd) •••
TSR 9Y CAGR (52.64%)
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) (0.05)
PE TTM —
TSR TTM (77.78%)
Mkt cap A$3.240M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0077
27.76%
(35.54%)
Hold 12|9|9|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
13.40%
5.44%
20.53%
12.32%
Revenue$M
0.229
0.239
0.241
0.235
5.41%
9.06%
12.59%
6.67%
Peers (US$2.225M)
Cap (US$)
PE
12.89M
99.65x
12.76M
—
2.051M
—
Capital
TTM
5Y
10Y
Leveragex
1.028
—
—
EBIT/Intx
0.167
0.166
0.180
Own earn%
33.32
(76.46)
(68.62)
Sh yield%
22.17
42.40
41.55
Owners
Insiders/Inst%
10.56
28.25
Short interest%
2.15
SBC / revenue%
2.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
13–20
$1 testx
0.0
Incr. ROIC%
25